Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Friday's After-Market Session

Author: Benzinga Insights | July 28, 2023 05:32pm

Gainers

  • Intelligent Bio Solutions (NASDAQ:INBS) stock rose 8.6% to $2.14 during Friday's after-market session. The company's market cap stands at $4.9 million.
  • MSP Recovery (NASDAQ:LIFW) shares increased by 6.68% to $0.23. The company's market cap stands at $76.1 million.
  • Mesoblast (NASDAQ:MESO) stock increased by 5.0% to $4.2. The market value of their outstanding shares is at $683.4 million.
  • Annexon (NASDAQ:ANNX) stock rose 4.98% to $3.37. The market value of their outstanding shares is at $178.8 million.
  • Matinas BioPharma Hldgs (AMEX:MTNB) shares increased by 4.87% to $0.39. The market value of their outstanding shares is at $85.7 million.
  • Renalytix (NASDAQ:RNLX) stock increased by 4.72% to $3.1. The market value of their outstanding shares is at $146.9 million.

Losers

  • OKYO Pharma (NASDAQ:OKYO) shares declined by 29.6% to $1.55 during Friday's after-market session. This security traded at a volume of 249.0K shares come close, making up 245.0% of its average volume over the last 100 days. The company's market cap stands at $39.5 million.
  • Science 37 Hldgs (NASDAQ:SNCE) shares declined by 7.14% to $0.25. The market value of their outstanding shares is at $29.1 million.
  • Impel Pharmaceuticals (NASDAQ:IMPL) stock fell 6.21% to $1.36. The market value of their outstanding shares is at $32.2 million.
  • OptiNose (NASDAQ:OPTN) stock fell 5.99% to $1.1. The company's market cap stands at $123.1 million.
  • eFFECTOR Therapeutics (NASDAQ:EFTR) shares decreased by 5.21% to $0.77. The company's market cap stands at $47.5 million.
  • Navidea Biopharmaceutical (AMEX:NAVB) stock declined by 5.16% to $0.09. Navidea Biopharmaceutical's trading volume hit 2.9 million shares by close, accounting for 40.5% of its average volume over the last 100 days. The market value of their outstanding shares is at $3.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ANNX EFTR IMPL INBS LIFW MESO MTNB NAVB OKYO OPTN RNLX SNCE


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist